NCT00340600View on ClinicalTrials.gov

Continuation of Follow-up of DES-Exposed Cohorts

CompletedOBSERVATIONAL
Enrollment

10,805

Participants

Timeline

Start Date

March 18, 1998

Primary Completion Date

September 30, 2015

Study Completion Date

November 13, 2020

Conditions
Breast CancerAutoimmune DiseaseProstate CancerOvarian CancerEndometrial Cancer
Trial Locations (1)

02118-2354

Boston University School of Public Health, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00340600 - Continuation of Follow-up of DES-Exposed Cohorts | Biotech Hunter | Biotech Hunter